Mycoplasma pneumoniae thymidine phosphorylase

Nucleosides, Nucleotides and Nucleic Acids

Volumn 33, Issue 4-6, 2014, Pages 296-304

  Wang, Liya ^a   Schmidl, Sebastian R ^b   Stülke, Jörg ^b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

growth inhibition; Mycoplasma pneumonia; nucleoside and nucleobase analogs; thymidine kinase; thymidine phosphorylase

Indexed keywords

ACICLOVIR; ADEFOVIR DIPIVOXIL; ALLOPURINOL; AZACITIDINE; AZATHIOPRINE; CAFFEINE; CIDOFOVIR; DIPROPHYLLINE; FLOXURIDINE; FLUCYTOSINE; FLUDARABINE PHOSPHATE; FLUOROURACIL; GANCICLOVIR; GEMCITABINE; IDOXURIDINE; LAMIVUDINE; MERCAPTOPURINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; PYRIMETHAMINE; RIBAVIRIN; STAVUDINE; THEOPHYLLINE; THYMIDINE PHOSPHORYLASE; TIOGUANINE; TRIFLURIDINE; UNINDEXED DRUG; VIDARABINE; ZALCITABINE; ZIDOVUDINE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; DEOXYURIDINE; THYMIDINE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; FOOD AND DRUG ADMINISTRATION; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIAE; NONHUMAN; NUCLEOTIDE METABOLISM; UPREGULATION; WILD TYPE; DEFICIENCY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUTATION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; DEOXYURIDINE; MUTATION; MYCOPLASMA PNEUMONIAE; THYMIDINE; THYMIDINE PHOSPHORYLASE;

EID: 84900455745     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2013.853783     Document Type: Article

References (18)

1. Razin, S.; Yogev, D.; Naot, Y. Molecular biology and pathogenicity of Mycoplasmas. Microbiol. Mol. Biol. Rev. 1998, 62, 1094-1156.
2. Waites, K.B.; Talkington, D.F. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 2004, 17, 697-728.
3. Lenglet, A.; Herrado, Z.; Magiorakos, A.; Leitmeyer, K.; Coulombier, D. Surveillance status and recent data for Mycoplasma pneumoniae infection in the European union and European economic area, January 2012. Euro. Surveill 2012, 17, 2-7.
4. Bebear, C.; Pereyre, S.; Peuchant, O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011, 6, 423-431.
5. Tsai, S.; Waer, D.J.; Shih, J.W.; Lo, S.C. Mycoplasmas and oncogenesis: persistant infection and multistage malignant transformation. Proc. Natl. Acad. Sci. USA 1995, 92, 10197-10201.
6. Yu, E.J.; Rha, S.Y.; Kim, T.S.; Chung, H.C.; Oh, B.K.; Ang, W.I.; Noh, S.H.; Jeung, H.C. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma. Mol. Cancer Res. 2008, 6, 1554-1566.
7. Namiki, K.; Goodison, S.; Porvasnik, S.; Allan, R.W.; Iczkowski, K.A.; Urbanek, C.; Reyes, L.; Sakamoto, N.; Rosser, C.J. Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS ONE 2009, 4, e6872.
8. Nishino, I.; Spinazzola, A.; Papadimitriou, A.; Hammans, S.; Steiner, I.; Hahn, C.; Connolly, A.; Verloes, A.; Guimaraes, J.; Maillard, I.; Hamano, H.; Donati, M.; Semrad, C.; Russell, J.; Andreu, A.; Hadjigeorgiou, G.; Vu, T.; Tadesse, S.; Nygaard, T.; Nonaka, I.; Hirano, I.; Bonilla, E.; Rowland, L.; DiMauro, S.; Hirano, M. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann. Neurol. 2000, 47, 792-800.
9. Akiyama, S.; Furukawa, T.; Sumizawa, T.; Takebayashi, Y.; Nakajima, Y.; Shimaoka, S.; Haraguchi, M. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression. Cancer Sci. 2004, 95, 851-857.
10. Bronckaers, A.; Balzarini, J.; Liekens, S. The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: implications for cancer therapy. Biochem. Pharmacol. 2008, 76, 188-197.
11. Bronckaers, A.; Gago, F.; Balzarini, J.; Liekens, S. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med. Res. Rev. 2009, 29, 903-953.
12. Vande Voorde, J.; Gago, F.; Vrancken, K.; Liekens, S.; Balzarini, J. Characterization of pyrimidine nucleoside phosphorylase of Mycoplasma hyorhinis: implications for the clinical efficacy of nucleoside analogues. Biochem. J. 2012, 445, 113-123.
13. Halbedel, S.; Stülke, J. Dual phosphorylation of Mycoplasma pneumoniae HPr by enzyme I and HPr kinase suggests an extended phosphoryl group susceptibility of HPr. FEMS Microbiol. Lett. 2004, 247, 193-198.
14. Wang, L.; Hames, C.; Schmidt, S.; Stülke, J. Upregulation of thymidine kinase activity compensates for loss of thymidylate synthase activity in Mycoplasma pneumoniae. Mol. Microbiol. 2010, 77, 1502-1511.
15. Wang, L.; Westberg, J.; Bölske, G.; Eriksson, S. Novel deoxynucleoside-phosphorylating enzymes in Mycoplasmas: evidence for efficient utilization of deoxynucleosides. Mol. Microbiol. 2001, 42, 1065-1073.
16. Sun, R.; Wang, L. Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs. BMC Microbiol. 2013, 13, 184.
17. Welin, M.; Egeblad, L.; Johansson, A.; Stenmark, P.; Wang, L.; Flodin, S.; Nyman, T.; Trésaugues, L.; Kotenyova, T.; Johansson, I.; Eriksson, S.; Eklund, H.; Nordlund, P. Structural and function studies of the human phosphoribosyltransferase domain containing protein 1. FEBS J. 2010, 277, 4920-4930.
18. Egeblad, L.; Welin, M.; Flodin, S.; Gräslund, S.; Wang, L.; Balzarini, J.; Eriksson, S.; Nordlund, P. Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. PLoS ONE 2012, 7, e37724.